Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Macular lipid membranes are specialized lipid bilayers located within the macula lutea of the retina, primarily constituting the photoreceptor outer segments and the retinal pigment epithelium (RPE). These membranes are characterized by an exceptionally high concentration of long-chain polyunsaturated fatty acids (PUFAs), particularly docosahexaenoic acid (DHA), which is vital for maintaining the high fluidity required for rapid phototransduction (Source: PubMed, PMID: 21840303). However, this unique lipid composition, combined with high oxygen consumption and exposure to high-energy blue light, renders the macula highly susceptible to oxidative damage and lipid peroxidation (Source: NIH, National Eye Institute). In conditions such as age-related macular degeneration (AMD) and Stargardt disease, the accumulation of oxidized lipids and toxic metabolic byproducts like lipofuscin (e.g., A2E) within these membranes leads to progressive cellular dysfunction and vision loss (Source: Wikipedia, Age-related macular degeneration). Therapeutic interventions targeting these membranes often involve the use of macular carotenoids like lutein and zeaxanthin, which act as physical filters for blue light and chemical antioxidants to neutralize reactive oxygen species (Source: AREDS2 Research Group). Emerging therapies also include the use of deuterated nutrients to stabilize carbon-hydrogen bonds against oxidative cleavage and drugs that target specific membrane lipids like cardiolipin to restore mitochondrial function (Source: Alkeus Pharmaceuticals; Stealth BioTherapeutics).
Stabilization of membrane fluidity, filtration of high-energy blue light, and neutralization of reactive oxygen species to prevent lipid peroxidation and the accumulation of toxic lipofuscin byproducts (Source: PubMed, PMID: 21840303; AREDS2).
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Macular lipid membranes.